RxDoctor Payments Data

Nicole Parker, APRN

Family · Sebastian, FLNPI 1912546755

Payments from drug & device makers

$4,378in general payments, 2019–2025

Across 36 payments — averaging $121.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$2K
  • Medtronic$1K
  • Boston Scientific$1K
  • Coloplast$264
  • Astellas Pharma US Inc$249
  • GE HealthCare$20

What the payments were for

  • Travel & lodging$3,23974%
  • Food & beverage$86320%
  • Education$2766%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teleflex LLC4$1,612
Medtronic17$1,198
Boston Scientific7$1,035
Coloplast3$264
Astellas Pharma US Inc4$249
GE HealthCare1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,378 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$53,179
Medicare patients
415
Services billed
943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron55$46,315
GemtesaVibegron30$30,756
ElmironPentosan Polysulfate Sodium11$13,664
Tamsulosin Hcl448$7,055
Solifenacin Succinate93$5,115
Estradiol56$3,173
Oxybutynin Chloride ErOxybutynin Chloride119$2,585
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst100$2,328
Testosterone22$2,259
Bethanechol Chloride55$2,184
Methenamine Hippurate23$1,957
Finasteride126$1,907
Testosterone Cypionate32$1,336
Ciprofloxacin Hcl88$1,154
Dutasteride20$653

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$249$46,31555 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.

Other family in Sebastian

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →